Inventor · disambiguated record
Ming-Tain Lai
Also filed as: LAI MING-TAIN
6 granted patents·12 pending applications·31 citations·filing 2001–2025
76Inventor score
Top patents by PatentIndex Score
18 records- 0187US7196163B2Assays using amyloid precursor proteins with modified β-secretase cleavage sites to monitor β-secretase activityMERCK & CO INC·Filed 2003·Granted Mar 27, 2007·26 cites·5 claims
- 0267US6753410B2Investigational compoundsMERCK & CO INC·Filed 2001·Granted Jun 22, 2004·2 cites·5 claims
- 0365US7135307B2Gamma three proteaseMERCK & CO INC·Filed 2002·Granted Nov 14, 2006·1 cites·19 claims
- 0463US12005072B2HIV drug combination for increasing barrier against resistanceMERCK SHARP & DOHME LLC·Filed 2019·Granted Jun 11, 2024·0 cites·15 claims
- 0559US2025276992A1Synthesis methods of acyl chain of qs-21 and derivative thereofOBI PHARMA INC·Filed 2023·Application pending·0 cites
- 0657US2025179191A1Bispecific dendritic cell engager and uses thereofLAI MING TAIN·Filed 2022·Application pending·0 cites
- 0756US2024084040A1Novel carbohydrate antibodies, pharmaceutical compositions and uses thereofOBI PHARMA INC·Filed 2022·Application pending·0 cites
- 0856US2024066125A1Globo series antigens-binding chimeric antigen receptors and uses thereofOBI PHARMA INC·Filed 2022·Application pending·0 cites
- 0955US7205336B2β-secretase inhibitorsMERCK & CO INC·Filed 2003·Granted Apr 17, 2007·2 cites·13 claims
- 1055US2025320299A1Bispecific dendritic cell engager and uses thereofOBI PHARMA INC·Filed 2025·Application pending·0 cites
- 1153US2024139301A1Active cancer immunotherapy by immune modulation via globo series antigensOBI PHARMA INC·Filed 2021·Application pending·0 cites
- 1250US11773118B2Methods of making high enantioselective secondary alcoholsOBI PHARMA INC·Filed 2020·Granted Oct 3, 2023·0 cites·20 claims
- 1350US2021093733A1Conjugated biological molecules, pharmaceutical compositions and methodsOBI PHARMA INC·Filed 2020·Application pending·0 cites
- 1449US2023056782A1Antibodies, pharmaceutical compositions and uses thereofLAI MING TAIN·Filed 2020·Application pending·0 cites
- 1549US2007219354A1Assays using amyloid precursor proteins with modified beta-secretase cleavage sites to monitor beta-secretase activityHAZUDA DARIA J·Filed 2007·Application pending·0 cites
- 1648US2025327822A1Companion diagnostic assay for globo-h related cancer therapyLAI MING TAIN·Filed 2020·Application pending·0 cites
- 1747US2024216401A1Combination therapy by using akr1c3-activated compound with immune checkpoint inhibitorOBI PHARMA INC·Filed 2021·Application pending·0 cites
- 1847US2024316079A1Use of akr1c3-activated compoundOBI PHARMA INC·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Ming-Tain Lai files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →